ZYROP 10000 I.U INJECTION
ZYROP 10000 I.U INJECTION

ZYROP 10000 I.U INJECTION

By ZYDUS LIFESCIENCES LIMITED

medicine_prescription
This medicine requires Prescription
MRP 2496.3
187525% OFF
Not for Online Sale
11 Alternative Available arrow

Product Summary

Offer Price1875
Your Savings ₹ 621.30 (25% on MRP)
Medicines with same composition as ZYROP 10000 I.U INJECTION

About ZYROP 10000 I.U INJECTION

  • ZYROP 10000 I.U INJECTION (EPO) is a glycoprotein hormone primarily produced by the kidneys, with a minor amount produced by the liver. It plays a crucial role in regulating red blood cell production, known as erythropoiesis. EPO stimulates the bone marrow to produce red blood cells, which are responsible for carrying oxygen throughout the body. It is used in the treatment of various conditions associated with anemia, such as chronic kidney disease, cancer-related anemia, and certain blood disorders.

Uses of ZYROP 10000 I.U INJECTION

  • Helps in anemia treatment
  • Used in chronic kidney disease
  • Treats blood disorders

How ZYROP 10000 I.U INJECTION Works

  • ZYROP 10000 I.U INJECTION stimulates the production of red blood cells in the bone marrow, increasing oxygen-carrying capacity and improving anemia.
  • ZYROP 10000 I.U INJECTION binds to specific receptors on the surface of progenitor cells in the bone marrow. This interaction triggers a signaling cascade, leading to the activation of genes involved in erythropoiesis. As a result, more red blood cells are produced from the bone marrow, maturing and entering the bloodstream. ZYROP 10000 I.U INJECTION also enhances the survival of these red blood cells by reducing apoptosis. The increased red blood cell count improves the oxygen-carrying capacity, alleviating anemia and improving tissue oxygenation. Furthermore, ZYROP 10000 I.U INJECTION has been shown to stimulate the release of reticulocytes, which are young red blood cells, from the bone marrow, further contributing to the replenishment of red blood cells in the circulation.

Dosage of ZYROP 10000 I.U INJECTION

  • Dosage for Children: The dosage of ZYROP 10000 I.U INJECTION for children varies depending on their age, weight, and specific medical condition. It should be determined by a pediatrician or healthcare professional.
  • Dosage for Adults: The recommended dosage of ZYROP 10000 I.U INJECTION for adults also varies depending on the underlying condition being treated. It should be prescribed and monitored by a healthcare professional.

Side Effects Of ZYROP 10000 I.U INJECTION

Common Side Effects of ZYROP 10000 I.U INJECTION
  • Hypertension
  • Thrombosis
  • Headache
  • Fatigue

How to Store ZYROP 10000 I.U INJECTION

  • Store in refrigerator (2-8°C)
  • Protect from light

Frequently asked questions about ZYROP 10000 I.U INJECTION

Common side effects of ZYROP 10000 I.U INJECTION include hypertension, thrombosis, headache, and fatigue.

ZYROP 10000 I.U INJECTION is primarily used in the treatment of anemia associated with chronic kidney disease, cancer-related anemia, and certain blood disorders.

ZYROP 10000 I.U INJECTION should only be used during pregnancy if the potential benefits outweigh the risks. Consult with a healthcare professional for guidance.

ZYROP 10000 I.U INJECTION can be administered through injections under the skin (subcutaneous) or directly into a vein (intravenous).

In some cases, ZYROP 10000 I.U INJECTION can be self-administered at home after appropriate training and under the guidance of a healthcare professional.

The time for ZYROP 10000 I.U INJECTION to show its effects may vary. Consult with a healthcare professional for a personalized assessment.

ZYROP 10000 I.U INJECTION may interact with certain medications, such as immunosuppressants or anticoagulants. Inform your healthcare provider about all medications you are taking.

The misuse of ZYROP 10000 I.U INJECTION in sports is considered doping and is strictly prohibited. Athletes should adhere to anti-doping regulations and ethical standards.

References related to ZYROP 10000 I.U INJECTION

  1. Okusa, M. D., & Balogun, R. A. (2010). Pharmacological Interventions in Acute Kidney Injury. 677–686. https://doi.org/10.1016/b978-1-4377-0987-2.00049-2 image
Customer Reviews

Mitula Patel

It's a seamless experience.

Reviewed on 08 Jan 2024

Mitula Patel

Reviewed on 08 Jan 2024

It's a seamless experience.

Yogesh Chawla

Good service and discount. Help me to get a good discount on some of my daily meds

Reviewed on 05 Aug 2023

Yogesh Chawla

Reviewed on 05 Aug 2023

Good service and discount. Help me to get a good discount on some of my daily meds

Geetika Purohit

Good services, rates are competitive!

Reviewed on 16 Jan 2024

Geetika Purohit

Reviewed on 16 Jan 2024

Good services, rates are competitive!

khunti mihir devshi

Best experience provided by medkart

Reviewed on 13 Jan 2024

khunti mihir devshi

Reviewed on 13 Jan 2024

Best experience provided by medkart

Pallav Bhatt

Good service. Public relations are very good.

Reviewed on 22 Nov 2022

Pallav Bhatt

Reviewed on 22 Nov 2022

Good service. Public relations are very good.

See More Reviews